bioshares

There'll be a few analysts out there looking through the top20 registers of micr-cap biotechs in the next few weeks...

When they tell you SBP is a good buy at under 12c the SBP s'price will be 14c.
When they say ; "on positive phase2 Pentrys results ACU is a spec buy at under 15c", ACU will be 18c.
PXL, IMU, NAL, SLT, PRR, BPH, PYC, BPO, and a few other candidates should get a bit of interst.

The trickles(profits from resource boom and general all ords growth) will be enough to initiate demand in this sector. After all the market caps are so low that it won't take a lot of money flowing into small biotechs to start the ball rolling.

Have a read of PTD last few releases. Alchemia has made a move. Progen has changed its CEO. AMP is now a substantial s'holder(as a re other fundies) in the small and mid-tier bios. Things are starting to take shape.
We might get some of our dough back. LOL